Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-28

Clinical Trial Update: Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression [NA]

View source ↗

Summary

Completed clinical trial examining the mechanism of Ganoderma lucidum spore powder in the treatment of depression. The study lists depression and thyroid cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ganoderma lucidum spore powder

Snippet

Sponsor: Ling Zhiqiang | Conditions: Depression, Thyroid Cancer | NA | Status: COMPLETED